Transamerica Financial Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Transamerica Financial Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-434	Closed	-$63K	–	719
2016 Q1	$63K	Buy	434 +27	+7%	+$3.83K	0.01%	348
2015 Q4	$63K	Sell	407 -3	-0.7%	-$438	﹤0.01%	377
2015 Q3	$59K	Buy	410 +63	+18%	+$8.81K	﹤0.01%	366
2015 Q2	$50K	Buy	347 +317	+1,057%	+$45.2K	﹤0.01%	457
2015 Q1	$5K	Buy	+30	New	+$4.62K	﹤0.01%	711

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Transamerica Financial Advisors's TARO Position: Q2 2016 in Review

Transamerica Financial Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2016, closing a stake of 434 shares — an estimated $63K sold.

Transamerica Financial Advisors first reported a position in TARO in Q1 2015 and held it in 5 quarters. The position peaked at $63K in Q1 2016. 159 funds tracked by Wall St. Rank hold TARO as of Q2 2016.

Transamerica Financial Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2016 after selling out during the quarter.
Transamerica Financial Advisors sold 434 Taro Pharmaceutical Industries Ltd. shares in Q2 2016, an estimated $63K.
Transamerica Financial Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2015 and held it in 5 quarters.
Transamerica Financial Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $63K in Q1 2016.
159 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2016.

Based on Transamerica Financial Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.